EUVIMED · CrossrefJournal
Journal of Viral Hepatitis
ISSN 1352-0504 · Wiley
Latest articles
Issue Information
Chronic Hepatitis B in the United States: Current Landscape, Unmet Needs and Future Directions
Anti‐Viral Treatment Eligibility and Treatment Uptake Among People With Chronic Hepatitis B in Australia: The REACH ‐B Study
Correction to ‘Geospatial Discrepancy of Chronic Hepatitis B and Hepatitis D Testing in Alberta: A Population‐Based Spatial Analysis’
Increasing HCV Diagnosis and Treatment Uptake Among Community‐Recruited People Who Inject Drugs in Athens, Greece, During the Transition to Unrestricted Access to Direct‐Acting Antivirals
Real‐World Effectiveness and Safety of Sofosbuvir‐Based Therapy in Chinese Children and Adolescents With Chronic HCV Infection: A Retrospective Multicentre Study
Associations Between Self‐Reported Previous Hepatitis C Diagnosis, Hepatitis C Treatment, and Current Binge Drinking Among Persons Who Inject Drugs—National HIV Behavioural Surveillance, 2015–2024
From Detecting Lesions to Delivering Care: Point‐of‐Care Ultrasound in Hepatitis B
Clinical Significance of Indeterminate Antibody to Hepatitis C in Cancer Patients
The Safety, Pharmacokinetics, and Antiviral Activity of ABI ‐4334, A Novel Next‐Generation Hepatitis B Capsid Assembly Modulator
Hepatitis B and D: Interferon‐Based Therapy—For Clinical Trials or Standard of Care—Back to the Future?
Regulatory T‐Cell Dynamics During and After Direct Acting Antivirals in Cirrhotic HCV Genotype 4 Patients
Triple Elimination of HIV, Syphilis and HBV Mother‐To‐Child Transmission in Africa: From a WHO Initiative to a Respondent‐Level Reality
A Randomized, Double‐Blind, Placebo‐Controlled Study of the PD‐1 Inhibitor Cetrelimab in Chronic Hepatitis B
Hepatitis A Virus ( HAV ) Recurrence and De Novo Hepatitis A Acquired at Time of Liver Transplantation: Comparison of Graft HAV Infection and Viral Kinetics
Validation of a Point‐Of‐Care Ultrasound for Hepatitis Among Front‐Line Healthcare Workers Managing Chronic Hepatitis B Virus Infection in Zambia
Geospatial Discrepancy of Chronic Hepatitis B and Hepatitis D Testing in Alberta: A Population‐Based Spatial Analysis
Issue Information
Monitoring of the Cascade of Care in Patients With Chronic HBV in Primary Care Clinics in Australia
Hepatocellular Carcinoma Risk Between Untreated Immune Tolerant Vs. Treated Immune Active Chronic Hepatitis B Patients
Nationwide Socioeconomic Evaluation of Direct‐Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023
Longitudinal Patterns of Chronic Hepatitis B Care and Treatment Adherence in Australia: A National Linked Data Cohort Study
Droplet Digital PCR Measurement of HBV DNA in On‐Treatment Chronic HBV Patients: Association With HCC Development and Outcomes
Trends in Mortality After the Roll‐Out of Directly Acting Antivirals for Hepatitis C in England Using Linked Surveillance Data
Differing Epidemiology of Chronic Hepatitis C Infection, Treatment, and Outcomes Among Migrants and Australian‐Born Patients
The Silent Burden of Hepatitis B‐Related Stigma
Trends in Hepatitis B, Hepatitis C, and HIV Seroprevalence in the Netherlands: Insights From Two Decades of Nationwide PIENTER Serosurveys
An Exploratory Cost‐Utility Analysis of Screening and Treating Immigrants in Canada for Hepatitis D
Prevention of HBV Mother‐To‐Child Transmission ( MTCT ) Using Targeted HBV Birth Dose, and Treatment of High Viral Load Pregnant Women in Uganda
Absence of Detectable Anti‐ HDV Antibodies Among HBsAg ‐Positive Blood Donors, HIV ‐Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay
Volumes
2026 · 1562025 · 1592024 · 1292023 · 1332022 · 1382021 · 2302020 · 1902019 · 2022018 · 5742017 · 1772016 · 1402015 · 3952014 · 2272013 · 2252012 · 1532011 · 1922010 · 1102009 · 1312008 · 1382007 · 1332006 · 1222005 · 962004 · 912003 · 742002 · 682001 · 732000 · 821999 · 661998 · 631997 · 911996 · 501995 · 471994 · 19
EUVIMED